ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Array Biopharma (ARRY)

Technical Analysis Report for NASDAQ stock ARRY Array Biopharma. Dated: 25 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma

Array Biopharma Opened at 7.75 and Closed at: 7.69, which is 0% of previous session's close. It moved within a range of 7.37 and 7.86
The session was a Bearish session with an average volume of 5758200, which is 23.81% of previous session's volumes.

  • Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.

A Dead cross was found 8 days back on mid term averages

Support for tomorrow is 7.29 and resistance for tomorrow is 7.78
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 7.42, 7.15 resistance for tomorrow's hourly charts is 7.91, 8.13

10 Day SMA for Array Biopharma (ARRY) is 7.87 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Array Biopharma (ARRY) is 8.15 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Array Biopharma (ARRY) is 8.16 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 8.36 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Array Biopharma is 8.59 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Array Biopharma is at 8.15 and 200 DMA is at 8.59, while 50 DMA and 100 DMA are at 8.16 and 8.36 respectively

Array Biopharma (ARRY) moving average of 20 SMA is at 8.15 and 20 EMA is at 8.02

Array Biopharma (ARRY) moving average of 50 SMA is at 8.16 and 50 EMA is at 8.12

Array Biopharma (ARRY) moving average of 100 SMA is at 8.36 and 100 EMA is at 8.25

Array Biopharma (ARRY) moving average of 200 SMA is at 8.59 and 200 EMA is at 8.19

Pulmatrix Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Pulmatrix Inc, about 37.96% more returns!

Nature S has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Nature S, about 11.59% more returns!

Biolife Solutions has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Biolife Solutions, about 25.86% more returns!

Biolinerx has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Biolinerx, about 3.86% more returns!

Coherus Biosciences has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Coherus Biosciences, about 6.65% more returns!

Crinetics Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Crinetics Pharmaceuticals, about 14.12% more returns!

Corvus Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Corvus Pharmaceuticals, about 21.35% more returns!

Array Biopharma has performed better than Editas Medicine in short term. Holding Array Biopharma could be a better choice for now!

Fortress Biotech has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Fortress Biotech, about 24.42% more returns!

Fortress Biotech has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Fortress Biotech, about 20.97% more returns!

Galectin Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 81.93% more returns!

Healthcare Services has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Healthcare Services, about 30.94% more returns!

Array Biopharma has performed better than Heron Therapeutics in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Helius Medical in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Jaguar Health in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma Technical analysis of indicators

Price action analysis of Array Biopharma (ARRY) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.

Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Array Biopharma in short term and SELL signal is strong!

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Array Biopharma is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 7.86 and Array Biopharma ARRY stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.

Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ARRY Experts View which covers a lot of information including buying and selling signals

ARRY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here

Chart Array Biopharma (ARRY)  Technical (Analysis) Reports Array Biopharma [

Videos related to: Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Array Biopharma (ARRY)  Technical (Analysis) Reports Array Biopharma [

 

Back to top